Close menu




Comments

Photo credits: pixabay.com

Commented by Armin Schulz on July 14th, 2025 | 07:00 CEST

Capitalizing on the central bank gold rush: Barrick Mining's production, Dryden Gold's exploration, and Deutsche Bank's interest rate concerns

  • Mining
  • Gold
  • Commodities
  • Investments
  • Banking

Gold is once again shining as a strategic anchor in turbulent times. Global central banks, especially those in emerging markets, are massively expanding their reserves, driven by geopolitical risks, currency diversification, and inflation concerns. At the same time, central banks like the ECB are lowering interest rates, which on the one hand offers banks cheaper refinancing, but on the other hand squeezes margins and increases credit risks. This dynamic mix of a gold rush, monetary policy shift, and inflationary pressure is forcing financial players to rethink their strategies. In this context, we take a look at two gold companies, Barrick Mining and Dryden Gold, and analyze the current outlook for Deutsche Bank.

Read

Commented by Fabian Lorenz on July 11th, 2025 | 07:20 CEST

Biotech takeover merry-go-round picks up speed! BioNTech, Evotec, Merck, and BioNxt Solutions!

  • Biotechnology
  • Biotech
  • Pharma

The takeover merry-go-round is spinning faster again in the biotech sector. The latest example is Merck's acquisition of Verona Pharma. The US group is paying USD 10 billion for the deal. BioNxt Solutions would be significantly cheaper to acquire at present. The Company aims to make it easier to take medication with melt films, skin patches, and tablets. In addition, it has now announced an exciting platform. The goal is to develop smarter chemotherapy, which, in turn, could create a billion-dollar market. And what are BioNTech and Evotec doing? Things have quieted down a bit at the German biotech leader following its billion-dollar deal with Bristol-Myers Squibb. However, analysts recommend buying the stock. Evotec, on the other hand, is languishing at around EUR 7. Can the quarterly figures provide new impetus for the struggling stock?

Read

Commented by Fabian Lorenz on July 11th, 2025 | 07:10 CEST

More than 100% price gain! Volkswagen, Standard Lithium, and BMW partner European Lithium! Comeback for EVs and lithium!

  • Mining
  • Lithium
  • Electromobility

Lithium shares are staging a comeback - without much attention. Standard Lithium's share price has already more than doubled in the current year. The US-based company is delivering strong news. European Lithium has also performed well recently. And for good reason: not only is the Company developing a large project in Europe, but it also has access to rare earths in Greenland. Will this soon make it a partner of the EU in building up a strategic reserve? After all, Volkswagen, BMW, and Mercedes need more and more batteries. While BYD and Tesla are currently struggling, German manufacturers are celebrating a comeback in the electric vehicle market, at least in Europe.

Read

Commented by Armin Schulz on July 11th, 2025 | 07:05 CEST

Rheinmetall, Argo Graphene Solutions, Vonovia: Three beneficiaries of the EUR 500 billion stimulus package

  • graphene
  • cement
  • Construction
  • Defense
  • RealEstate

Germany's economy is facing a billion-dollar gamble. Government super-write-offs and a EUR 500 billion special fund are fueling investment in infrastructure and defense. Record budgets of EUR 115 billion for roads, networks, and education, as well as EUR 86 billion for arms modernization, are creating unprecedented opportunities. Those who join now can benefit from Germany's largest restructuring in decades. But where are the best prospects? Today, we look at three companies that could profit from these investments in defense and infrastructure: Rheinmetall, Argo Graphene Solutions, and Vonovia.

Read

Commented by Nico Popp on July 11th, 2025 | 07:00 CEST

Think locally, benefit globally: JinkoSolar, Kontron, naoo

  • AI
  • Digitization
  • IoT
  • Solar

It is old news that decentralized solutions are better - those who understand how village communities were largely self-sufficient and supported each other complementarily just a few decades ago know the blueprint for economic success. Decentralized solutions have long played a key role in energy supply. The boom in private solar installations shows that resourceful property owners have recognized the potential. But other industries also benefit when complementary elements are brought together.

Read

Commented by Nico Popp on July 10th, 2025 | 10:30 CEST

Breaking news: Volatus Aerospace secures $10 million in financing – analysis and background

  • volatus
  • Drones
  • Defense
  • financing
  • nato
  • droneshield

Things are moving fast at Volatus Aerospace, the Canadian drone specialist for civil and military applications: Following two orders for drones and drone training from a NATO country, the Company has now secured growth financing. The Company announced overnight that it intends to raise up to CAD 10 million through a non-brokered “LIFE Offering.” This means that the new shares are not subject to any lock-up period. The financing will support expansion in the area of tactical ISR and logistics services and prepare for growth investments. The capital will thus flow into precisely those areas in which Volatus Aerospace has recently demonstrated its ability to win orders: military reconnaissance and logistics.

Read

Commented by Nico Popp on July 10th, 2025 | 07:25 CEST

Small-cap disrupts billion-dollar market: Johnson & Johnson, Merck KGaA, and NetraMark

  • Biotechnology
  • Biotech
  • AI
  • healthtech

When it comes to making people healthy, progress is what matters most. New drugs must be better and safer than old ones. To ensure that these requirements are met, comprehensive testing procedures are carried out by drug regulatory authorities. However, despite ever-expanding knowledge and modern methods, almost 90% of clinical trials still fail. When considering that the development of a drug costs an average of USD 2.6 billion and usually takes more than ten years, it becomes clear what a risk biotech companies and pharmaceutical multinationals are taking. This is precisely where NetraMark's business model comes in, offering the entire industry unparalleled leverage.

Read

Commented by Fabian Lorenz on July 10th, 2025 | 07:20 CEST

Hydrogen Stocks: Are Nel and Plug Power on the way out? Is it better to bet on thyssenkrupp nucera and Pure Hydrogen?

  • Hydrogen
  • greenhydrogen
  • renewableenergies

Australia has a good chance of playing a key role in the future hydrogen market – particularly when it comes to green hydrogen from renewable sources. CSIRO and Deloitte see billions in potential. Pure Hydrogen aims to profit from this. The Australians are currently building a hydrogen ecosystem and have celebrated initial sales successes and are already concluding global partnerships. The stock is anything but expensive and remains an insider tip. Nel, on the other hand, is floundering this year. The euphoria surrounding Samsung's entry has fizzled out. Will there be new impetus next week? Perhaps new funding? Meanwhile, thyssenkrupp nucera is making bold moves. On the one hand, the Company has secured technology from the insolvent Danish company Green Hydrogen Systems and secured a million-dollar contract from Saudi Arabia.

Read

Commented by Armin Schulz on July 10th, 2025 | 07:15 CEST

How BioNTech, PanGenomic Health, and Pfizer are using artificial intelligence to cut costs and boost returns

  • Biotechnology
  • healthtech
  • Biotech
  • AI

Digitalization is revolutionizing the biotechnology and pharmaceutical industries. Artificial intelligence sifts through billions of pieces of medical data in real time, accelerating drug development by years. This is also demonstrated by the new alliance between Moderna and Google Cloud, which are jointly developing an AI platform for customized mRNA cancer therapies. These technologies reduce production costs by up to 40% and generate disruptive return opportunities. At the same time, personalized medicine is opening up billion-dollar markets. Three companies are turning to artificial intelligence to boost their returns: BioNTech, PanGenomic Health, and Pfizer.

Read

Commented by Nico Popp on July 10th, 2025 | 07:10 CEST

German government kicks off hydrogen boost: Rheinmetall, thyssenkrupp, First Hydrogen

  • Hydrogen
  • cleantech
  • Defense
  • Steel

The German government is stepping on the hydrogen gas pedal: Simplified approvals and accelerated construction of electrolysers, import terminals, pipelines, and storage facilities are intended to make German industry fit for the future. Hydrogen is of "overriding public interest," according to a draft law obtained by the news agency dpa. This is good news for companies in the hydrogen economy that have gained momentum in recent years. Planning security can give the emerging industry the boost it needs, and it is essential for the transformation of German industry.

Read